PRESENTATION

Q3 2022 — Presentation

Q3 2022PDF · 33 pages621 KB
Presentation to Investors and Analysts
HSBC Holdings plc 3Q22 Results

-- 1 of 33 --

Appendix	3Q22 results
Our purpose, values and ambition support the execution of our strategy
Opening up a world of opportunity	Our purpose
Our values
Our strategy
Our ambition To be the preferred international financial partner for our clients
We value difference 	We succeed together 	We take responsibility 	We get it done
Focus on our strengths 	Digitise at scale 	Energise for growth 	Transition to net zero

-- 2 of 33 --

2
Appendix	3Q22 results
3Q22 highlights
4 Adjusted costs stable vs. 9M21, on track to deliver broadly stable costs in FY22. 3Q22 costs
of $7.3bn up 5% vs. a low 3Q21 base
3
3Q22 ECL charge of $1.1bn reflects developments in mainland China’s CRE market and
heightened economic uncertainty and inflation in the UK; Stage 1 and 2 charges of $0.6bn, Stage 3
charges remain low at $0.4bn
1 Good set of results; reported PBT of $3.1bn, including $2.4bn impairment related to the planned
disposal of our French retail business; adjusted PBT of $6.5bn, up $1.0bn (18%) vs. 3Q21
5 CET1 ratio1 of 13.4% down 0.2ppts vs. 2Q22, including c.0.3ppts impact from planned French
retail disposal, intend to be in target range during 1H23
A reconciliation of reported results to adjusted results can be found on slide 13, the remainder of the presentation unless otherwise stated, is presented on an adjusted basis
Figures throughout this presentation may be subject to rounding adjustments and therefore may not sum precisely to totals given in charts, tables or commentary
2 Adjusted revenue of $14.3bn, up $3.1bn (28%) vs. 3Q21; strong NII, up $2.5bn (40%) vs. 3Q21;
non-NII up $0.6bn (13%) vs. 3Q21

-- 3 of 33 --

3
Appendix	3Q22 results
3Q22 results summary
$m 	3Q22 	3Q21 	Δ
NII 	8,564 	6,097 	40%
Non-NII 	5,739 	5,100 	13%
Revenue 	14,303 	11,197 	28%
ECL 	(1,075) 	561 	>(100)%
Costs 	(7,300) 	(6,926) 	(5)%
Associates 	581 	676 	(14)%
Adjusted PBT 	6,509 	5,508 	18%
Significant items and FX translation 	(3,362) 	(105) 	>(100)%
Reported PBT 	3,147 	5,403 	(42)%
Reported earnings per share, $ 	0.10 	0.18 	$(0.08)
Impact of sig items on reported EPS, $ 	(0.13) 	(0.02) 	$(0.11)
Reported RoTE 2 (YTD, annualised), % 	9.2 	9.1 	0.1ppts
$bn 	3Q22 	2Q22 	Δ
Customer loans 	968 	985 	(2)%
Customer deposits 	1,567 	1,584 	(1)%
Reported RWAs 	828 	852 	(3)%
CET1 ratio 1, % 	13.4 	13.6 	(0.2)ppts
TNAV per share, $ 	7.13 	7.48 	$(0.35)
 	Good set of 3Q22 results, reported PBT of $3.1bn; adjusted PBT of
$6.5bn up $1.0bn (18%) vs. 3Q21
 	Revenue of $14.3bn, up $3.1bn (28%) vs. 3Q21, strong NII growth, up
$2.5bn (40%) vs. 3Q21 due to higher rates; non-NII up $0.6bn (13%) vs.
3Q21, with lower fees offset by strong trading income
 	ECL charge of $1.1bn vs. a net release of $0.6bn in 3Q21
 	Costs of $7.3bn, up 5% vs. 3Q21. Increased technology spend,
performance-related pay accrual and inflation were partly offset by $0.6bn of
cost saves
 	Associate income down $0.1bn (14%) primarily due to non-repeat of a
3Q21 gain within BGF
 	Significant items up, mainly $2.4bn relating to the re-classification of our
French retail operations to held for sale (HFS) and $0.7bn restructuring and
other related costs
 	Customer lending down $18bn (2%) vs. 2Q22 due to $23bn of French
loans moved to HFS. Excl. this impact, lending up $5bn (1%)
 	Customer deposits down $16bn (1%) vs. 2Q22 due to $21bn of French
deposits moved to HFS. Excl. this impact, deposits up $5bn (0%)
 	CET1 ratio of 13.4% down 0.2ppts vs. 2Q22, includes negative
movements of c.0.3ppts relating to planned French disposal, and 0.1ppts of
fair value movements
 	TNAV per share of $7.13, down vs. 2Q22 due to negative FX and fair value
movements

-- 4 of 33 --

4
Appendix	3Q22 results
Adjusted revenue performance
1,248
1,226
537
3Q21 	WPB 	CMB 	GBM
95
Corporate
Centre
3Q22
11,197
14,303
+28%
Revenue by global business, $m
 	Global Liquidity and Cash Management (GLCM) was renamed Global
Payments Solutions (GPS) during 3Q22
 	WPB up $1.2bn (25%):
 Personal Banking up $1.4bn (51%), primarily due to higher rates and
balance sheet growth
 Wealth down $0.2bn (9%), adverse insurance market impacts of
$0.4bn and lower equity sales from muted market sentiment in Hong
Kong more than offset good insurance VNB and higher Private Banking
NII; continued strong franchise build with net new invested assets
of $91bn since 3Q21
 	CMB up $1.2bn (40%), primarily GPS (up $1.1bn) from higher rates and
balance sheet growth
 	GBM up $0.5bn (16%):
 MSS up $0.4bn (20%), benefitting from market volatility, with a
continuing strong FX performance
 Banking up $0.3bn (18%), as lower Capital Markets & Advisory activity
was offset by GPS up $0.4bn (100%), due to higher rates and organic
growth
Includes $375m of
adverse insurance
market impacts
FY21 adjusted revenue at reported FX was $50.1bn, retranslated at September YTD constant currency FX rates: $46.9bn

-- 5 of 33 --

5
Appendix	3Q22 results
2,208 	2,251 	2,259 	2,208 	2,171
157bps
119bps 	126bps	119bps 135bps
+22bps
Net interest income and margin
 3Q22 reported NII of $8.6bn was up $2.0bn (30%) vs.
3Q21, primarily due to rate rises
 3Q22 adjusted NII up $2.5bn (40%) vs. 3Q21, and up
$1.3bn (19%) vs. 2Q22
 3Q22 reported NIM of 1.57%, up 22bps vs. 2Q22 as
asset yield growth more than offset increased liability
costs
 FY22 NII guidance has been upgraded to c.$32bn
 Upgrading FY23 overall revenue assumptions (on a
constant currency basis):
 Now expect FY23 NII of at least $36bn3 vs.
previous guidance of ≥$37bn due to FX translation
impacts of $1.2bn, primarily sterling weakness*
 FY23 NII guidance assumes increased trading book
funding costs (interest expense) of at least $1.3bn vs.
2Q22 guidance, with an equal and opposite increase
in trading income, both booked in Corporate Centre4 ,
due to higher short-term rates in FY23
 Our NII assumptions for 2023 are cautious at this early
stage, given recent volatility in FX and interest rate
markets
 Expect low single-digit percentage lending growth in both
FY22 and FY23
Reported NIM trend
Discrete quarterly
reported NIM
Average interest
earning assets
(AIEAs), $bn
Reported NII, $m
of which:
significant items
17
8,581
4Q21
6,781
0
3Q21
(7) 	(2)
1Q22
(12)
6,610
2Q22 	3Q22
6,997 7,454
Reported NIM progression, bps
25
2Q22 	Significant items	Rise in rates
1	(4)
3Q22	FX
135
157
* The $1.2bn is the difference between June month average FX and September month average FX; FY21 adjusted revenue at reported FX was $50.1bn, retranslated at September YTD constant currency FX rates: $46.9bn; FY21 adjusted costs at reported FX
were $32.1bn, retranslated at September YTD constant currency FX rates: $30.0bn
 Trading booking funding costs can be volatile; >$1.3bn is our current planning assumptions for additional funding costs in FY23 vs. 1H22 guidance

-- 6 of 33 --

6
Appendix	3Q22 results
Non-NII
WPB, $m 	CMB, $m 	GBM, $m	Group non-NII, $m
3Q21 	2Q22 	3Q22
1,412 1,225 	1,268
(10)% 	+4%
Wealth Mgmt 	Pers. Bnking 	Other
3Q21 	2Q22 	3Q22
850 	908 	911
+7% 	0%
GPS 	Other
3Q21 	3Q22	2Q22
876 724 625
(29)% 	(14)%
Capital Mkts & Advisory 	Other
3,117 	2,864 	2,783
1,983 	2,607 	2,956
3Q21 	2Q22 	3Q22
5,100 5,471 5,739
+13% 	+5%
330 	431
127
3Q21 	2Q22 	3Q22
(62)% 	(71)%
188 	95 252
2Q22	3Q21 	3Q22
+34% 	+165% 	1,476 1,802 	1,811
2Q22	3Q21 	3Q22
+23% 	0%
 Down vs. 3Q21 due to insurance
manufacturing market impacts; down
vs. 2Q22 due to a gain on policyholder
funds held on deposit
 Up 34%, mainly higher GBM
collaboration revenue due to higher FX
demand
 Up 23%, primarily trading income due
to a strong FX performance during
3Q22 in volatile market conditions
 Net fees down 11% vs. 3Q21,
mainly GBM and Wealth
 Other income up $1.0bn (49%)
vs. 3Q21, good Markets
performance and includes trading
book funding adjustments in
Corporate Centre recorded as
interest expense4
 Down 10%, lower Wealth in Asia, as
muted equity market conditions led to
lower investment distribution activity
 Up 7%, growth mainly in GPS (up 18%
following repricing initiatives)
 Down 29% due to lower Capital
Markets & Advisory activity; GPS fees
up 8% vs. 3Q21
Net fees 	Net fees 	Net fees
Other income 	Other income 	Other income
Other income	Net fees

-- 7 of 33 --

7
Appendix	3Q22 results
(0.23) 	0.20 	0.26 	0.18 	0.43
Credit performance
Adjusted ECL charge / (release) trend
 	3Q22 ECL net charge of $1,075m
 	Stage 1 and Stage 2 charges of $0.6bn, of
which:
 $0.3bn relates to our China CRE portfolio
 $0.2bn in respect of an uncertain UK
macroeconomic outlook, taken in the UK RFB
 	Stage 3 charges remain low at $0.4bn, of
which $0.1bn relates to offshore China CRE
 	Stage 3 loans were 1.8% of total customer
loans, stable vs. 2Q22
 	Expect ECL charge to normalise around 30bps
in FY22
 	We currently expect the FY23 ECL charge to be
towards the top end of our through-the-cycle
planning range of 30-40bps
 	At 2Q22, a 100% weighting to the Downside 2
scenario in our IFRS 9 models would generate an
additional $5.6bn of ECL. Changed forward
economic guidance has increased this to $6.6bn
at 3Q22
ECL charge /
(release) as a %
of average
gross loans and
advances
3Q22 ECL charge / (release) by stage, $bn	ECL charge / (release) by geography, $m
(561)
478 	619 433
1,075
3Q22	3Q21 	1Q22	4Q21 	2Q22
ECL, $m
Stage 1-2 	Stage 3 	Total
Wholesale 	0.5 	0.3 	0.8
Personal 	0.1 	0.1 	0.2
Total 	0.6 	0.4 	1.1
3Q22 	2Q22
Hong Kong* 	503 	214
Mainland China 	89 	62
Other Asia 	74 	(61)
UK RFB 	279 	124
HSBC Bank plc 	(15) 	(7)
Mexico 	91 	140
Other 	54 	(39)
Total 	1,075 	433
* Charges largely relate to offshore China CRE exposures booked on Hong Kong balance sheets
 Total includes an additional $0.1bn ECL charge to other assets

-- 8 of 33 --

8
Appendix	3Q22 results
7,356
6,926 	6,926
Adjusted costs
Operating expenses trend, $m
1,303 1,407 1,480 	1,480 	1,493
7,259
5,832
3Q22
7,727
3Q21
116
6,204
4Q21 	1Q22
5,779
2Q22
5,807
6,926 7,312 	7,300
Other Group costs 	UK bank levy	Technology 5
3Q22 vs. 3Q21, $m	3Q22 vs. 2Q22, $m
 	3Q22 costs of $7.3bn, up $0.4bn (5%) vs. a low 3Q21 base. Cost saves were
offset by $0.3bn higher technology spend and $0.2bn higher performance-related
pay (PRP) accrual as a result of timing differences. 9M22 costs of $22.7bn, broadly
stable vs. 9M21
 	3Q22 cost saves of $0.6bn had associated CTA of $0.7bn. Programme cost
saves to date of $4.9bn had associated CTA spend of $5.3bn
 	We expect to deliver our planned cost savings with a CTA spend between $6.5-
$7bn. Expect cost savings at the high end of our $5-$5.5bn range by the end of
FY22 and a further c.$1bn of cost saves expected to flow through in FY23
 	Continue to expect broadly stable costs in FY22*; targeting c.2% cost growth in
FY233
221
320
416
Other items	3Q21
6,926
(583)
Cost
saves
PRP 	Tech
spend6
7,300
3Q22
+5%
* FY21 adjusted costs at reported FX were $32.1bn, retranslated at September YTD constant currency FX rates $30.0bn
 Other items includes business and volume growth of $0.1bn, inflation of $0.1bn, litigation and other one-off items of $0.2bn
‡ Reflects the impact of retranslating the prior year results of our operations in hyperinflationary economies at current year
average foreign exchange rates
50
136
7.259
2Q22
(136)
Cost Saves
(9)
PRP 	Tech
spend6
Other items
7.300
3Q22
+1%
Includes $58m of
hyperinflation ‡
5,623

-- 9 of 33 --

9
Appendix	3Q22 results
 	CET1 ratio of 13.4%, down 0.2ppts vs. 2Q22 due to:
 Impairment related to movement of French retail
operations to held-for-sale: 0.3ppts
 Negative after-tax OCI movements: 0.1ppts
 Partly offset by profits net of dividend accrual: +0.2ppts
 	Reported RWAs of $828bn, down $23bn (3%) vs. 2Q22,
primarily due to FX translation
 	We intend to manage our CET1 ratio towards 14% in
4Q22 and intend to be within our target CET1 ratio range
during 1H23
 	CET1 ratio target range remains at 14%–14.5% in the
medium term, with the intention of managing this range
down further longer term
 	Achieved RWA savings of $120bn to date as part of our
transformation programme
Capital adequacy
3Q22 	2Q22 	3Q21
Common equity tier 1 capital, $bn 	111 	116 	133
Reported risk-weighted assets, $bn 	828 	852 	839
CET1 ratio, % 	13.4 	13.6 	15.9
Leverage ratio exposure, $bn 	2,415 	2,484 	2,965
Leverage ratio 1, % 	5.4 	5.5 	5.2
Capital progression1
CET1 ratio, %
0.2
Impact of
French
HFS 7
2Q22 	Profits (net
of dividend
accrual)8
Change
in RWAs
0.0
FX
translation
differences
Movements
through OCI
Other 	3Q22
13.6
(0.3)
(0.1)
0.0
(0.1)
13.4
115.8
851.7
110.8	CET1, $bn
RWAs, $bn 	828.3	(27.8)
(3.7) 	0.0	1.8
4.4
(1.0)	(2.0)

-- 10 of 33 --

10
Appendix	3Q22 results
Summary
* On a constant currency basis; see slide 5 for details on NII/revenue
 Excluding significant items
‡ On a reported basis
4 	Intend to be in our CET1 ratio target range during 1H23
2 Expect an ECL charge around 30bps in FY22; credit quality of the book remains strong, expect to
be towards the top end of our 30-40bps planning range in FY23
1 Good set of results; adjusted PBT of $6.5bn, up 18% vs. 3Q21; rising rates and strong markets
income offset higher investment spend and a net ECL charge
5 	9M22 annualised RoTE of 10.8%; continue to target 12%+ RoTE‡ in FY23
3 	FY23 overall revenue assumptions upgraded*; targeting c.2% adjusted cost growth 3
6 We expect to have a 50% dividend payout ratio for FY23 and FY24; we aim to return excess
capital to shareholders where appropriate

-- 11 of 33 --

Appendix

-- 12 of 33 --

12
Appendix	3Q22 results
Key financial metrics
Reported results, $m 	3Q22 	2Q22 	3Q21
NII 	8,581 	7,454 	6,610
Other Income 	3,035 	5,318 	5,402
Revenue 	11,616 	12,772 	12,012
ECL 	(1,075) 	(448) 	659
Costs 	(7,975) 	(8,107) 	(7,989)
Associate income 	581 	793 	721
Profit before tax 	3,147 	5,010 	5,403
Tax 	(586) 	762 	(1,161)
Profit after tax 	2,561 	5,772 	4,242
Profit attributable to ordinary shareholders (‘PAOS’) 	1,913 	5,486 	3,543
Basic EPS, $ 	0.10 	0.28 	0.18
Diluted EPS, $ 	0.10 	0.27 	0.17
DPS (declared in respect of the period), $ 	— 	0.09 	—
Net interest margin (annualised), % 	1.57 	1.35 	1.19
Alternative performance measures, $m 	3Q22 	2Q22 	3Q21
Adjusted NII 	8,564 	7,227 	6,097
Adjusted other income 	5,739 	5,471 	5,100
Adjusted revenue 	14,303 	12,698 	11,197
Adjusted ECL 	(1,075) 	(433) 	561
Adjusted costs 	(7,300) 	(7,259) 	(6,926)
Adjusted associate income 	581 	769 	676
Adjusted profit before tax 	6,509 	5,775 	5,508
PAOS excl. goodwill and other intangible impairment and PVIF 	2,865 	5,012 	3,492
Return on average tangible equity (annualised) 2, % 	7.8 	13.3 	8.7
Return on average equity (annualised) 2, % 	4.7 	13.0 	8.0
Adjusted net loans and advances to customers, $bn 	968 	985 	948
Adjusted customer accounts, $bn 	1,567 	1,584 	1,540
Adjusted cost efficiency ratio, % 	51.0 	57.2 	61.9
ECL charge/(release) as a % of average gross loans and
advances to customers (annualised) 0.43 	0.18 	(0.23)
Reported balance sheet, $bn 	3Q22 	2Q22 	3Q21
Total assets 	2,992 	2,985 	2,969
Net loans and advances to customers 	968 	1,028 	1,040
Customer accounts 	1,567 	1,651 	1,688
Quarterly average interest-earning assets 	2,171 	2,208 	2,208
Reported loan/deposit ratio 	61.7 	62.3 	61.6
Total shareholders’ equity (NAV) 	178 	188 	198
Tangible ordinary shareholders’ equity (TNAV) 	141 	148 	158
NAV per share, $ 	8.00 	8.41 	8.70
TNAV per share, $ 	7.13 	7.48 	7.81
Capital, leverage and liquidity1 	3Q22 	2Q22 	3Q21
Reported risk-weighted assets, $bn 	828 	852 	839
CET1 ratio, % 	13.4 	13.6 	15.9
Total capital ratio (transitional), % 	18.1 	18.6 	21.3
Leverage ratio, % 	5.4 	5.5 	5.2
High-quality liquid assets (liquidity value), $bn 	606 	657 	664
Liquidity coverage ratio, % 	127 	134 	135
Share count, m 	3Q22 	2Q22 	3Q21
Basic number of ordinary shares outstanding 	19,738 	19,819 	20,201
Basic number of ordinary shares outstanding and dilutive
potential ordinary shares 19,857 	19,949 	20,296
Quarterly average basic number of ordinary shares outstanding 	19,752 	19,884 	20,213

-- 13 of 33 --

13
Appendix	3Q22 results
Reconciliation of reported PBT and adjusted profit after tax
* Primarily comprises losses associated with our RWA reduction programme
$m 	3Q22 	2Q22 	3Q21
Reported PBT (B) 	3,147 	5,010 	5,403
Revenue
Currency translation 	— 	(470) 	(1,000)
Customer redress programmes 	(17) 	12 	—
Disposal, acquisitions and investment in new businesses 	2,440 	288 	—
Fair value movements on financial instruments 	232 	58 	64
Restructuring and other related costs* 	32 	11 	125
Currency translation of significant items 	— 	27 	(4)
ECL 	Currency translation 	— 	15 	(98)
Operating expenses
Currency translation 	— 	287 	705
Customer redress programmes 	(15) 	(10) 	7
Disposals, acquisitions and investment in new businesses 	9 	— 	—
Impairment of goodwill and other intangibles 	— 	9 	—
Restructuring and other related costs 	681 	589 	397
o/w: costs to achieve	
676 	583 	390
Currency translation of significant items 	— 	(27) 	(46)
Share of profit in associates and JVs 	Currency translation 	— 	(24) 	(45)
Adjusted PBT 	6,509 	5,775 	5,508
Tax
Currency translation 	— 	36 	112
Reported tax (charge) / credit 	(586) 	762 	(1,161)
Tax significant items 	(648) 	(1,935) 	(69)
Currency translation on significant items 	— 	— 	6
Adjusted profit after tax (A) 	5,275 	4,638 	4,396
Total tax, currency translation and significant items (A-B) 	2,128 	(372) 	(1,007)

-- 14 of 33 --

14
Appendix	3Q22 results
Certain items included in adjusted revenue
Certain items included in adjusted revenue
highlighted in management commentary, $m 3Q22 	2Q22 	1Q22 	4Q21 	3Q21
Insurance manufacturing market impacts in WPB 	(418) 	(380) 	(280) 	125 	(43)
of which: Asia WPB insurance manufacturing market
impacts
(442) 	(400) 	(362)	
88	
(51)
Gain on Insurance policyholder funds on deposit in WPB 	— 	294 	— 	— 	—
Credit and funding valuation adjustments in GBM 	3 	24 	(29) 	38 	(41)
Legacy Credit in Corporate Centre 	(6) 	23 	(18) 	(12) 	(34)
Valuation differences on long-term debt and associated
swaps in Corporate Centre (48) 	(32) 	5 	(10) 	(35)
Turkey hyperinflation9 	(28) 	(113) 	— 	— 	—
Argentina hyperinflation10 	(106) 	(86) 	(69) 	(18) 	(24)
Total 	(603) 	(270) 	(391) 	123 	(177)

-- 15 of 33 --

15
Appendix	3Q22 results
(187)
1,438
56
15
1,076
79
370
283
429
(107)
(9)
95
(426) 	3,106
(3)
3Q22 adjusted revenue performance
3Q22 revenue 	3Q22 vs. 3Q21 	Revenue by global business, $bn
5.0 	5.5 6.3
3.1 3.6
4.3
3.3
3.7
3.8
(0.1)	(0.2)
14.3
3Q21
(0.1)
11.2
2Q22 	3Q22
12.7
+28%
CMB
GBM
Corporate Centre
WPB
o/w XVAs: $44m
o/w valuation
differences: $(13)m
25%
40%
16%	
of which: GPS
Principal Investments
GPS
GTRF
Credit and Lending
Other
Wealth
Other
$6,286m
$4,309m
$3,823m
$(115)m
$14,303m 	28%
$1,901m
$(21)m
$859m
$2,209m
$485m
$1,899m
$1,407m
$518m
$123m
MSS
WPB
CMB
GBM
Corp. Centre
Group
Impact of certain items
Banking 	$1,825m
Other 	$(190)m
Personal Banking 	$4,262m
o/w insurance market
impacts: $(375)m

-- 16 of 33 --

16
Appendix	3Q22 results
Net interest margin supporting information
3Q21 	4Q21 	1Q22 	2Q22 	3Q22 % of 3Q22
Group NII
% of 3Q22
Group AIEA
The Hongkong and
Shanghai Banking
Corporation (HBAP)
1.35% 	1.35% 	1.39% 	1.46% 	1.79% 	51% 	45%
HSBC Bank plc 	0.47% 	0.52% 	0.55% 	0.57% 	0.41% 	5% 	21%
HSBC UK Bank plc
(UK RFB) 1.51% 	1.48% 	1.63% 	1.77% 	1.99% 	23% 	18%
HSBC North America
Holdings, Inc 0.90% 	0.87% 	0.90% 	1.05% 	1.16% 	6% 	8%
Quarterly NIM by key legal entity
Key rates (quarter averages), bps
7 	11 	20 	31
164
257
9 	8 	12
77
219
308
10 	13
45
95
162
225
2Q22	3Q21 	4Q21 	4Q22 QTD*	1Q22 	3Q22
1M HIBOR
Fed effective rate
BoE Base Rate
Source: Bloomberg 	* At 21 October 2022
1 year NII sensitivity
Parallel change
from July 2022
to Jun 2023
Currency
USD 	HKD 	GBP 	EUR 	Other 	Total
$m 	$m 	$m 	$m 	$m 	$m
+25bps 	109 	183 	356 	111 	399 	1,158
-25bps 	(120) 	(188) 	(393) 	(104) 	(409) 	(1,214)
+100bps 	433 	720 	1,513 	460 	1,571 	4,697
-100bps 	(881) 	(1,254) 	(1,677) 	(419) 	(1,723) 	(5,954)
At 30 June 2022, using a simplified pass-through assumption of 50%
5 year NII sensitivity
Parallel change
from July 2022
to Jun 2027
Currency
USD 	HKD 	GBP 	EUR 	Other 	Total
$m 	$m 	$m 	$m 	$m 	$m
+25bps 	850 	1,011 	3,002 	622 	2,519 	8,004
-25bps 	(896) 	(1,017) 	(3,081) 	(606) 	(2,585) 	(8,185)
+100bps 	3,354 	4,028 	12,128 	2,561 	9,952 	32,023
-100bps 	(5,623) 	(6,617) 	(12,483) 	(2,556) 	(10,776) 	(38,055)
At 30 June 2022, using a simplified pass through assumption of 50%

-- 17 of 33 --

17
Appendix	3Q22 results
3Q22 financial highlights
Revenue 	$6.3bn 25%
(3Q21: $5.0bn)
ECL 	$(0.3)bn >(100)%
(3Q21: $0.2bn)
Costs 	$(3.6)bn (3)%
(3Q21: $(3.5)bn)
PBT 	$2.4bn 35%
(3Q21: $1.8bn)
RoTE 11 	15.2% (2.0)ppts
(9M21: 17.2%)
(10)%
1,097 	1,019 	968
542 542 	506
3Q21 	2Q22 	3Q22
1,639 1,561 1,474
(6)%
435 	453 	432
778 	806 	779
2Q22	3Q21 	3Q22
(1)%
0%
+25%
+14%
(380) 	(418)	(43) 	125 	(280)
2,131 	1,809 	2,121 	2,532 	2,319
2,824 	2,905 	2,987 3,369 	4,262	129	126
4Q21	3Q21 	1Q22
90 2
2Q22
123
3Q22
Wealth and Personal Banking
Wealth excl. market impacts
Personal banking
Other
Balance sheet, $bn
Reported Wealth Balances, $bn
3Q22 vs. 3Q21
 Revenue up $1.2bn (25%). Personal banking up $1.4bn (51%)
primarily from interest rate rises and global balance sheet growth.
Wealth down $187m, including adverse movement in market
impacts of $375m and lower investment distribution, partly offset
by higher Private Banking and Insurance VNB
 Customer lending down $3bn (1%) due to $23bn French loans
moved to held for sale (HFS). Excl this impact, up $20bn from
$18bn growth in mortgages and $3bn unsecured
 Customer accounts up $1bn despite $21bn French deposits
moved to HFS. Excl. this impact, up $22bn with growth particularly
in the UK and Asia
 Wealth balances down $165bn (10%). NNIA of $91bn in the last
12 months, (incl. $32bn this quarter) was more than offset by lower
market levels and adverse FX impacts of $221bn
3Q22 vs. 2Q22
 Revenue up $763m (14%). Personal banking up $893m (27%),
primarily due to rate rises. Wealth down $251m (12%), primarily
due to the non-repeat of a $294m gain on policyholder funds on
deposit in Insurance, partly offset by higher Private Banking NII
 Customer lending down $21bn (5%) due to $23bn loans moved
to HFS. Excl. this impact, up $2bn, including mortgage growth of
$3bn and $1bn of unsecured
 Customer accounts down $27bn (3%) from $21bn deposits
moved to HFS and outflows in Hong Kong to investments
 Wealth balances down $87bn (6%). NNIA of $32bn was more
than offset by lower market levels and adverse FX impacts of
$83bn and a $36bn reduction in wealth deposits
Insurance manufacturing
market impacts
5,038 	4,968 	4,918 	5,523 	6,286
Wealth deposits12
Invested assets
Customer
lending
Customer
accounts
23
French HFS
portfolio
21
Revenue performance, $m

-- 18 of 33 --

18
Appendix	3Q22 results
+40%
+4%
+6%
Commercial Banking
Balance sheet, $bn
3Q21 	2Q22 	3Q22
315 335	334
0%
3Q21 	2Q22 	3Q22
444 	459 	460
0%
Customer lending
Customer accounts
Revenue performance, $m
GPS (formerly GLCM)
Credit & Lending
GTRF
Markets products, Insurance
and Investments and Other
823 	870 	952 	1,304 1,899
1,392 	1,452 	1,392 1,427
1,407	462 	477 	508 519
518
439
485
3,291
1Q22	3Q21 	2Q22
406 	335
4Q21
306
3Q22
3,083 	3,134 3,556
4,309
+21%
3Q22 financial highlights
Revenue 	$4.3bn 40%
(3Q21: $3.1bn)
ECL 	$(0.7)bn >(100)%
(3Q21: $0.2bn)
Costs 	$(1.6)bn (2)%
(3Q21: $(1.5)bn)
PBT 	$2.1bn 17%
(3Q21: $1.8bn)
RoTE 11 	13.7% 2.1ppts
(9M21: 11.6%)
3Q22 vs. 3Q21
 Revenue up $1.2bn (40%) across all products with double digit
growth in all regions notably in Asia and the UK. GPS revenue up
>100%, driven by higher rates, higher balances and 18% fee
growth. Strong growth in Trade (up 12%) and GBM Collaboration
income (up 23%)
 ECL up $0.9bn, reflecting build-up of provisions due to a
weakening forward economic outlook and Chinese commercial
real estate exposures
 Customer lending up $20bn (6%) with growth across all
regions notably in North America, Asia and the UK with Credit &
Lending (up $14bn, 6%) and Trade (up $5bn, 10%)
 Customer accounts up $16bn (4%) with growth notably in Asia
($13bn) and Canada ($3bn)
3Q22 vs. 2Q22
 Revenue up $753m (21%) with growth across all regions
notably in Asia and the UK, continued growth in GPS (up 46%),
higher markets treasury allocations and collaboration income
 Customer lending was broadly stable with continued growth in
Credit & Lending partly offset by slowing momentum in Trade
 Customer accounts were broadly stable

-- 19 of 33 --

19
Appendix	3Q22 results
Global Banking and Markets
View of adjusted revenue
Adjusted RWAs13, $bn
1,839 	1,728 2,229 	2,256 	2,209
1,542 	1,556
1,559 	1,699 	1,825
1Q22 	2Q22
(95) 	(70)
3,823
3Q21
(69)
4Q21
(262) 	(211)
3Q22
3,286 	3,214
3,719 	3,693
+16% 	+4%
MSS 	Banking 	Other
Revenue performance, $m
$m 	3Q22 ∆3Q21
MSS 	2,209 	20%
Securities Services 	525 	9%
Global Debt Markets 	112 	(27)%
Global FX 	1,065 	49%
Equities 	260 	(20)%
Securities Financing 	244 	19%
XVAs 	3 	>100%
Banking 	1,825 	18%
GTRF 	185 	10%
GPS (
formerly GLCM) 	859 	100%
Credit & Lending 	552 	(6)%
Capital Markets &
Advisory 179 	(43)%
Other 	50 	14%
GBM Other 	(211) >(100)%
Principal Investments 	(21) >(100)%
Other 	(190) 	(5)%
Net operating income 	3,823 	16%
3Q21 	3Q22	2Q22
234 	235 	238
+2% 	+2%
3Q22 financial highlights
Revenue 	$3.8bn 16%
(3Q21: $3.3bn)
ECL 	$(0.1)bn >(100)%
(3Q21: $0.1bn)
Costs 	$(2.2)bn (5)%
(3Q21: $(2.1)bn)
PBT 	$1.5bn 15%
(3Q21: $1.3bn)
RoTE 11 	11.8% 1.7ppts
(9M21: 10.1%)
3Q22 vs. 3Q21
 GBM Revenue of $3.8bn up $0.5bn (16%)
 MSS revenue of $2.2bn up $0.4bn (20%):
• 	Global FX and Securities Financing driven by strong trading
performance, continued strong client flow and disciplined risk
management
• 	Global Debt Markets and Equities down due to lower client
activity and challenging primary market conditions
• 	Securities Services growth driven by global interest rate
increases, partly offset by reduced fees from lower market
levels
 Banking revenue of $1.8bn up $0.3bn (18%):
• 	GPS growth reflecting higher global interest rates as well as
growth in deposit balances and fee income
• 	Capital Markets & Advisory down due to subdued market
conditions
3Q22 vs. 2Q22
 Revenue up $0.1bn (4%):
• 	MSS down 2% against a strong Q2
• 	Banking up 7%, as rising interest rates supported strong GPS
results

-- 20 of 33 --

20
Appendix	3Q22 results
3Q22 financial highlights
Revenue 	$(115m) 45%
(3Q21: $(210)m)
ECL 	$0m (100)%
(3Q21: $2m)
Costs 	$59m (67)%
(3Q21: $181m)
Associates 	$568m (14)%
(3Q21: $662m)
PBT 	$512m (19)%
(3Q21: $635m)
RoTE 11 	4.6% (0.8)ppts
(3Q21: 5.4%)
Corporate Centre
Revenue performance, $m
509 	536 623 	648 478
93
568
70	66
(2)
3Q21
12
4Q21 	1Q22
(19)
119 2
2Q22
(2)
3Q22
662 	618 	602
769
87
(26)%
Associate income detail, $m
3Q21 	4Q21 	1Q22 	2Q22 	3Q22
Central Treasury 	(35) 	(10) 	5 	(32) 	(48)
Legacy Credit 	(34) 	(12) 	(18) 	23 	(6)
Other 	(141) 	(98) 	(222) 	(65) 	(61)
Total 	(210) 	(120) 	(235) 	(74) 	(115)
Not included in Corporate Centre revenue: Markets
Treasury revenue allocated to global businesses
485	
458	
473	
358	
365
BoCom 	Others	SABB
3Q22 vs. 2Q22
 Revenue down $41m (55%), primarily due to non-recurrence of
valuation gains in Legacy Credit in 2Q22 and adverse valuation
differences
 Associates down $201m (26%), primarily due to a lower share of
profits in BoCom in 2Q22 which we report one quarter in arrears
3Q22 vs. 3Q21
 Revenue up $95m (45%), primarily due to FX gains on revaluation
and non-recurrence of loss on disposal of legacy portfolios in the
US in 3Q21
 Associates down $94m (14%), primarily due to the non-repeat of
a 3Q21 gain in BGF in the UK
Adjusted RWAs13 , $bn
53
31
3Q21
50
32
2Q22
47
31
3Q22
83 	82 78
(6)% 	(4)%
Associates 	Other

-- 21 of 33 --

21
Appendix	3Q22 results
Shareholders’
Equity, $bn
Tangible Equity,
$bn
TNAV per share,
$
Basic number of ordinary
shares, million
As at 30 June 2022 	188.4 	148.3 	7.48 	19,819
Profit attributable to: 	2.4 	3.2 	0.16 	—
Ordinary shareholders 14	
1.9	
3.2	
0.16	
—
Other equity holders	
0.5	
—	
—	
—
Dividends 	(2.2) 	(1.8) 	(0.09) 	—
On ordinary shares	
(1.8)	
(1.8)	
(0.09)	
—
On other equity instruments	
(0.5)	
—	
—	
—
FX
14 	(6.3) 	(5.8) 	(0.29) 	—
Cancellation of shares 	— 	— 	0.03 	(83)
Actuarial gains/(losses) on defined benefit plans 	(0.5) 	(0.5) 	(0.02) 	—
Cash flow hedge reserves 	(2.7) 	(2.7) 	(0.14) 	—
Fair value movements through ‘Other Comprehensive Income’ 	(0.2) 	(0.2) 	(0.01) 	—
Of which: changes in fair value arising from changes in own credit risk	
0.8	
0.8	
0.04	
—
Of which: Debt and Equity instruments at fair value through OCI	
(1.0)	
(1.0)	
(0.05)	
—
Other
14 	(1.2) 	0.2 	0.01 	2
As at 30 September 2022 	177.7 	140.7 	7.13 	19,738
 Average basic number of shares outstanding during 3Q22: 19,752
 3Q22 TNAV per share decreased by $0.35 to $7.13 per share, mainly due to adverse FX
impact, cash flow hedge reserve movements and dividends paid during the quarter, partly offset by
higher profits
$7.09 on a fully diluted
basis
19,857 million on a
fully diluted basis
3Q22 vs. 2Q22 equity drivers

-- 22 of 33 --

22
Appendix	3Q22 results
Total shareholders’ equity to CET1 capital
3Q22 	2Q22 	1Q22 	4Q21
Total equity (per balance sheet) 	185,993 	196,690 	204,658 	206,777
Non-controlling interests 	(8,335) 	(8,308) 	(8,365) 	(8,527)
Total shareholders’ equity 	177,658 	188,382 	196,293 	198,250
Additional Tier 1 	(19,746) 	(21,691) 	(22,414) 	(22,414)
Total ordinary shareholders' equity 	157,912 	166,691 	173,879 	175,836
Foreseeable dividend 	(3,926) 	(3,548) 	(5,197) 	(3,655)
Share buyback 	— 	— 	(1,000) 	—
Adjustment for insurance / SPE’s*,15 	4 	(12,881) 	(13,479) 	(13,449)
Allowable NCI in CET1 	4,272 	4,392 	4,297 	4,186
CET1 before regulatory adjustments 	158,262 	154,654 	158,500 	162,918
Prudential valuation adjustment 	(1,334) 	(1,299) 	(1,419) 	(1,217)
Intangible assets 	(11,082) 	(11,746) 	(11,899) 	(9,123)
Deferred tax asset deduction 	(3,528) 	(3,274) 	(1,579) 	(1,520)
Cash flow hedge adjustment 	4,669 	2,124 	1,297 	170
Excess of expected loss 	(1,992) 	(2,373) 	(2,304) 	(2,020)
Own credit spread and debit valuation adjustment 	(1,589) 	(778) 	671 	1,571
Defined benefit pension fund assets 	(5,639) 	(6,638) 	(7,797) 	(7,146)
Direct and indirect holdings of CET1 instruments 	(40) 	(40) 	(40) 	(40)
Other regulatory adjustments to CET1 capital
(including IFRS 9 transitional adjustments when
relevant)
(340) 	(235) 	223 	766
Threshold deductions* 	(26,630) 	(14,615) 	(14,206) 	(11,794)
Regulatory adjustments 	(47,505) 	(38,874) 	(37,053) 	(30,353)
CET1 capital 	110,757 	115,780 	121,447 	132,565
Allowable NCI in CET1
4
Additional Tier 1
Non-controlling interests
158,262
(8,335)
Total equity
Regulatory adjustments
CET1 capital
4,272
(3,926)
Deconsolidation of
insurance / SPE’s
Foreseeable
dividend
Total ordinary
shareholders’ equity
(19,746)
185,993
Total shareholders’
equity
157,912
110,757
CET1 before
regulatory adjustments
(47,505)
177,658
Total equity to CET1 capital, at 30 September 2022, $m 	Total equity to CET1 capital walk, $m
* These rows include offsetting entries of $12,660m relating to the start of equity accounting for our insurance subsidiaries with effect from 3Q22

-- 23 of 33 --

23
Appendix	3Q22 results
Impacts of financial investments
Hold-to-collect-and-sell (‘HTC&S’) debt portfolio, $bn
 	As part of our interest rate hedging strategy, we hold a debt portfolio of financial
investments measured at fair value through other comprehensive income (‘FVOCI’),
which are classified as hold-to-collect-and-sell
 	The increase in term market yield curves in 3Q22 drove $0.9bn of additional post-tax
losses through OCI; cumulative 9M22 post-tax losses through OCI were $5.8bn
(0.7ppts of CET1). Over time, these adverse movements will unwind as the instruments
reach maturity, although not all instruments will necessarily be held to maturity
 	HTC&S portfolio size down to $271bn at 3Q22 vs. $347bn at FY21
 	We have taken actions in 9M22 to reduce the duration risk of this portfolio and
the overall capital volatility of our hedging instruments, including decreasing the
amount of securities held under HTC&S (measured at FVOCI) and prospectively
increased those held under to hold-to-collect (measured at amortised cost)
 	In 9M22, yields of US Treasuries, UK Gilts, and German Bunds of maturities ranging
from 6 months to 10 years experienced the following average increases, with
associated post-tax losses through OCI of the HTC&S portfolio of:
 	1Q22: 83bps and $3.1bn; 2Q22: 70bps and $1.8bn; 3Q22: 146bps and $0.9bn*
 	The Group continues to be positively exposed to global interest rate movements. If
policy rates were to follow market expectations, higher NII is expected to offset FVOCI
losses through increased profitability in approximately 4 quarters from 9M22
* Source: Bloomberg
 Based on a static portfolio composition
347
271
FY21 	3Q22
(22)%

-- 24 of 33 --

24
Appendix	3Q22 results
3Q21 	2Q22 	3Q22
+2%
Balance sheet – customer lending
968
315
198
197
432	435
1
334
453
1
335
201
0
948 985
(2)%
Balances by global business, $bn
Corporate Centre
GBM
CMB
WPB
Adjusted customer lending of $968bn,
down $18bn (2%) vs. 2Q22 due to the
reclassification of $23bn of French loans to
held for sale (HFS). Excl. this impact,
lending up $5bn (1%)
 WPB lending decreased by $21bn
(5%) due to reclassification of French
assets to held for sale. Excl. this
impact, up $2bn (0)%
 CMB lending stable with growth in
Credit & Lending partly offset by lower
Trade
 GBM lending increased $3bn (1%),
predominantly in Europe
Balances by region, $bn
Europe
Asia
MENA
North
America
o/w: US
Total
o/w: Hong
Kong
o/w: UK
Latin
America
$(7)bn
(2)%
2
$1bn
1%
$(0)bn
(1)%
$7bn
3%
1
$(17)bn
(5)%
$(3)bn
(1)%
$(0)bn
(0)%
$1bn
6%
$(18)bn
(2)%
Growth since 2Q22
o/w: mortgages
o/w: mortgages
$323bn
$480bn
$28bn
$114bn
$24bn
$968bn
$267bn
$304bn
$57bn

-- 25 of 33 --

25
Appendix	3Q22 results
+2%
806
1,540 0
3Q21
778
318
444
1
318
459
1
2Q22
779
460
328
3Q22
1,584 	1,567
(1)%
Balance sheet – customer accounts
Balances by global business, $bn
Adjusted customer accounts of
$1,567bn, down $16bn (1%) vs. 2Q22 due
to the reclassification of $21bn of French
deposits to held for sale (HFS). Excl. this
impact, deposits up $5bn (0%)
 WPB customer accounts down
$27bn (3%) due to reclassification of
$21bn of France balances to HFS and
Hong Kong outflows into investments
 CMB customer accounts stable
 GBM customer accounts up $10bn
(3%) as customers have increased
average balances and liquidity
 Average GPS (formerly GLCM) balances
down $2bn (0%) vs. 2Q22 to $767bn;
up $34bn (5%) vs. 3Q21	GBM
Corporate Centre
CMB
WPB
Balances by region, $bn
Europe
Asia
MENA
North
America
o/w: US
Total
o/w: Hong
Kong
o/w: UK
Latin
America
$(3)bn
(3)%
$(7)bn
(1)%
$1bn
3%
$9bn
2%
$(12)bn
(2)%
$(15)bn
(3)%
$1bn
1%
$1bn
1%
$(16)bn
(1)%
Growth since 2Q22
$570bn
$756bn
$44bn
$166bn
$31bn
$1,567bn
$470bn
$528bn
$98bn

-- 26 of 33 --

26
Appendix	3Q22 results
Hong Kong loans and deposits
US$bn 	%
Reported net loans and advances to customers 	311.9 	100%
Personal lending 	130.6 	42%
o/w: Mortgages 	98.0 	31%
o/w: Credit cards 	7.9 	3%
o/w: Other personal lending 	24.7 	8%
Corporate and commercial lending 	161.1 	52%
o/w: Real estate 	62.2 	20%
o/w: Other corporate and commercial 	98.9 	32%
Non-bank financial institutions 	20.2 	6%
Memo: Group HK$ denominated net loans and advances 	223.7
HSBC Hong Kong balance sheet
 c.31% of FY21 customer loans were mortgages; Hong Kong mortgages are
substantially all HK$ lending
 Market convention for trade facility pricing is 3-month US$ LIBOR/SOFR; HSBC Hong
Kong FY21 trade market share17 of 23%
 Corporate lending is a mixture of revolver and term lending; market convention for HK$
corporate term lending uses 1 or 3-month HIBOR
At 31 December 2021
HKMA system data16 , HK$tn
Source: HKMA. Data at 31 December 2021
US$bn
Reported customer accounts 	549.4
Memo: Group HK$ denominated deposits 	318.7
System loans to customers 	System deposits
HK$
41%
59%
By type
7%
16%
77%
By currency
Other
10.9 	10.9
Trade financing 17
Mortgages
Other
Other
49%
37%
15%
15.2
By currency
US$
HK$

-- 27 of 33 --

27
Appendix	3Q22 results
6.344 	1.570
By booking centre
Hong
Kong
Mainland
China RoW 	Total
Loans and advances to customers18 9,773 	6,488 	441 	16,702
Guarantees issued and others18 1,961 	1,026 	94 	3,081
Total 	11,734 	7,514 	535 	19,783
By credit quality
Strong 	2,095 	2,117 	145 	4,357
Good 	2,429 	2,898 	58 	5,385
Satisfactory 	3,104 	2,272 	175 	5,551
Sub-standard 	1,946 	95 	157 	2,198
Credit impaired 	2,160 	132 	— 	2,292
Total 	11,734 	7,514 	535 	19,783
Allowance for ECL 	(884) 	(103) 	(3) 	(990)
Mainland China commercial real estate update
30%
18%
23%
21%
29%
26% 	17%
4%
18%
14%
1H22
FY21
Good	Strong 	Satisfactory 	Sub-Standard 	Credit Impaired
Hong Kong booked exposure, distribution by credit quality
Mainland China CRE exposures at 30 June 2022, $m
 We report our detailed exposure information at the half year and full
year
 Real Estate business to mainland China is highly selective,
focused on top tier developers with project lending concentrated in Tier
1 cities and Tier 2 cities. However, the Chinese CRE market is being
impacted by the structural and policy changes that are taking place
 As at 30 September 2022, the ECL allowance against the offshore
portfolio is $1.3bn. An additional charge of $0.4bn was taken during
3Q22 as a result of CRR downgrades, FEG deterioration and increased
PD assumptions in CRE overlays

-- 28 of 33 --

28
Appendix	3Q22 results
HSBC Bank Canada financial information
9M22 	FY21
NII 	1,155 	1,226
Non-NII 	679 	989
Revenue 	1,834 	2,215
ECL 	(82) 	45
Costs 	(964) 	(1,308)
PBT 	788 	952
Tax 	(210) 	(235)
Profit attributable to shareholder 	578 	717
Reported return on average common
shareholder’s equity, % 14.5 	11.7
Reported profit and loss account, CADm 	Selected balance sheet information, CADm
3Q22 	FY21
Total assets 	134,047 	119,853
o/w: Loans and advances to customers 	75,672 	68,699
o/w: Goodwill and intangible assets 	196 	181
Total liabilities 	128,311 	112,977
o/w: Customer accounts 	81,500 	73,626
Total shareholder’s equity 	5,736 	6,876
o/w: Preferred shares 	1,100 	1,100
o/w: Tangible equity 	4,440 	5,595
Selected capital measures
3Q22 	FY21
CET1 capital, CADm 	4,919 	5,590
Reported RWAs, CADm 	44,481 	39,836
CET1 ratio 19, % 	11.1 	14.0
Tier 1 ratio, % 	13.5 	16.8
Reported revenue and lending by global business, CADm
39%
49%
48%
45%
Revenue
at 9M22
75,672
1%
12%
6%
0%
1,834
Lending
WPB 	CMB 	Corporate Centre	GBM
 In 1H22 HSBC Canada paid CAD313m of dividends
At 30 September 2022

-- 29 of 33 --

29
Appendix	3Q22 results
Glossary
AIEA 	Average interest earning assets
AT1 	Additional Tier 1
BGF 	Business Growth Fund, an associate of HSBC
BoCom 	Bank of Communications Co. Limited, an associate of HSBC
Bps 	Basis points. One basis point is equal to one-hundredth of a percentage point
CET1 	Common Equity Tier 1
Corporate Centre Corporate Centre comprises Central Treasury, our legacy businesses, interests in our associates
and joint ventures and central stewardship costs
CMB 	Commercial Banking, a global business
CRE 	Commercial Real Estate
CRR 	Customer risk rating
CTA 	Costs to achieve
C&L 	Credit & Lending
DPS 	Dividend per share
ECL
Expected credit losses. In the income statement, ECL is recorded as a change in expected credit
losses and other credit impairment charges. In the balance sheet, ECL is recorded as an
allowance for financial instruments to which only the impairment requirements in IFRS 9 are
applied
EPS 	Earnings per share
FEG 	Forward economic guidance
FVOCI 	Fair value through other comprehensive income
GBM 	Global Banking and Markets, a global business
GPS 	Global Payments Solutions (formerly GLCM: Global Liquidity and Cash Management)
Group 	HSBC Holdings plc and its subsidiary undertakings
GTRF 	Global Trade and Receivables Finance
HFS 	Held for sale
HIBOR 	Hong Kong Interbank Offered Rate
HKD 	Hong Kong Dollar
IFRS 	International Financial Reporting Standard
Legacy credit
A portfolio of assets including securities investment conduits, asset-backed securities, trading
portfolios, credit correlation portfolios and derivative transactions entered into directly with
monoline insurers
MENA 	Middle East and North Africa
MSS 	Markets and Securities Services
NAV 	Net asset value
NCI 	Non-controlling interests
NIM 	Net interest margin
NNIA 	Net new invested assets
OCI 	Other Comprehensive Income
PBT 	Profit before tax
PD 	Probability of default
Ppt 	Percentage points
PRP 	Performance related pay
PVIF 	Present value of in-force insurance contracts
SABB 	The Saudi British Bank, an associate of HSBC
SPE 	Special-purpose entity
RoTE 	Return on average tangible equity
RWA 	Risk-weighted asset
TNAV 	Tangible net asset value
UK RFB 	HSBC UK, the UK ring-fenced bank, established July 2018 as part of ring fenced bank legislation
VNB 	Value of new business written
WPB 	Wealth and Personal Banking, a global business
XVAs 	Credit and Funding Valuation Adjustments

-- 30 of 33 --

30
Appendix	3Q22 results
Footnotes
1. 	Unless otherwise stated, regulatory capital ratios and requirements are based on the transitional arrangements of the Capital Requirements Regulation in force at the time. These include the
regulatory transitional arrangements for IFRS 9 ‘Financial Instruments’. The leverage ratio is calculated using the end point definition of capital and the IFRS 9 regulatory transitional arrangements, in
line with the UK leverage rules that were implemented on 1 January 2022, and excludes central bank claims. Comparatives for 2021 are reported based on the disclosure rules in force at that time,
and include claims on central banks. References to EU regulations and directives (including technical standards) should, as applicable, be read as references to the UK’s version of such regulation
and/or directive, as onshored into UK law under the European Union (Withdrawal) Act 2018, and subsequently amended under UK law
2. 	Reported RoTE is computed by adjusting annualised reported results for PVIF and for impairment of goodwill and other intangible assets (net of tax), divided by average reported equity adjusted for
goodwill, intangibles and PVIF for the period
3. 	On an IFRS 4 basis
4. 	Corporate Centre includes an adjustment to reverse an accounting asymmetry relating to the cost of internally sourced funding of our trading activities, which is recorded as an expense within net
trading income in the relevant global business. The adjustment moves this funding cost out of net trading income and into net interest income as an interest expense, reflecting the substance of the
accounting treatment for the consolidated Group. This elimination has nil impact on Corporate Centre revenue
5. 	Technology costs in operating expenses trends include transformation saves and are presented on a net basis
6. 	Technology cost increases in quarterly walks are presented on a gross basis (excl. saves)
7. 	Impact of planned French disposal includes post-threshold impacts
8. 	Regulatory profits, net of regulatory dividend accrual for the purposes of capital calculations. In the 9 months to 30 September 2022, we accrued $5.7bn after excluding the impact of the deferred tax
asset created in 2Q22 and loss on reclassification of French retail operations to held for sale; equivalent to 28¢ per voting share
9. 	From 1 June 2022, Turkey was deemed a hyperinflationary economy for accounting purposes
10. From 1st July 2018, Argentina was deemed a hyperinflationary economy for accounting purposes
11. YTD, annualised. RoTE by Global Business excludes significant items. RoTE methodology annualises Profits Attributable to Shareholders, including ECL, in order to provide a returns metric. RoTE by
Global Business considers AT1 Coupons on an accruals basis, vs. Reported RoTE where it is treated on a cash basis
12. Wealth deposits include Premier, Jade and Global Private Banking deposits, which include Prestige deposits in Hang Seng Bank, and form part of the total WPB customer accounts balance
13. A reconciliation of reported RWAs to adjusted RWAs can be found in the ‘HSBC Holdings plc 3Q 2022 Datapack’
14. Differences between shareholders’ equity and tangible equity drivers primarily reflect AT1 capital, goodwill and other intangibles and PVIF. ‘Profit Attributable to Ordinary shareholders’ differences
primarily include goodwill and other intangibles impairment, PVIF movements and amortisation expense. ‘FX’ differences primarily include FX on goodwill and intangibles. ‘Other’ differences
primarily include intangible additions and redemption of securities
15. A revised approach to insurance-related adjustments has been effective from 30 September 2022. This has no impact on overall CET1 capital
16. System refers to authorised institutions under the supervision of the HKMA
17. Trade financing lending is comprised of: loans to finance imports to and exports and re-exports from Hong Kong; loans to finance merchandising trade not touching Hong Kong; and, acceptance and
bills of exchange. Source: HKMA at 31 December 2021; Hong Kong market share includes HASE
18. Mainland China reported Real Estate exposures comprises exposures booked in mainland China and offshore where the ultimate parent is based in mainland China, and all exposures booked on
mainland China balance sheets; Commercial Real Estate refers to lending that focuses on commercial development and investment in real estate and covers commercial, residential and industrial
assets; Real Estate for Self Use refers to lending to a corporate or financial entity for the purchase or financing of a property which supports overall operations of a business i.e. a warehouse for an e-
commerce firm
19. The common equity tier 1 and tier 1 ratios are calculated as the respective capital base divided by risk-weighted assets, in accordance with CAR Guideline issued by OSFI

-- 31 of 33 --

31
Appendix	3Q22 results
Disclaimer
Important notice
The information, statements and opinions set out in this presentation and accompanying discussion (“this Presentation”) are for informational and reference purposes only and do not constitute a public offer for the purposes of any
applicable law or an offer to sell or solicitation of any offer to purchase any securities or other financial instruments or any advice or recommendation in respect of such securities or other financial instruments.
This Presentation, which does not purport to be comprehensive nor render any form of legal, tax, investment, accounting, financial or other advice, has been provided by HSBC Holdings plc (together with its consolidated subsidiaries,
the “Group”) and has not been independently verified by any person. You should consult your own advisers as to legal, tax investment, accounting, financial or other related matters concerning any investment in any securities. No
responsibility, liability or obligation (whether in tort, contract or otherwise) is accepted by the Group or any member of the Group or any of their affiliates or any of its or their officers, employees, agents or advisers (each an “Identified
Person”) as to or in relation to this Presentation (including the accuracy, completeness or sufficiency thereof) or any other written or oral information made available or any errors contained therein or omissions therefrom, and any such
liability is expressly disclaimed.
No representations or warranties, express or implied, are given by any Identified Person as to, and no reliance should be placed on, the accuracy or completeness of any information contained in this Presentation, any other written or
oral information provided in connection therewith or any data which such information generates. No Identified Person undertakes, or is under any obligation, to provide the recipient with access to any additional information, to update,
revise or supplement this Presentation or any additional information or to remedy any inaccuracies in or omissions from this Presentation. Past performance is not necessarily indicative of future results. Differences between past
performance and actual results may be material and adverse.
Forward-looking statements
This Presentation may contain projections, estimates, forecasts, targets, opinions, prospects, results, returns and forward-looking statements with respect to the financial condition, results of operations, capital position, strategy and
business of the Group which can be identified by the use of forward-looking terminology such as “may”, “will”, “should”, “expect”, “anticipate”, “project”, “plan”, “estimate”, “seek”, “intend”, “target”, “believe”, "potential" and
"reasonably possible" or the negatives thereof or other variations thereon or comparable terminology (together, “forward-looking statements”), including the strategic priorities and any financial, investment and capital targets and any
ESG related targets, commitments and ambitions described herein. Any such forward-looking statements are not a reliable indicator of future performance, as they may involve significant stated or implied assumptions and subjective
judgements which may or may not prove to be correct. There can be no assurance that any of the matters set out in forward-looking statements are attainable, will actually occur or will be realised or are complete or accurate. The
assumptions and judgments may prove to be incorrect and involve known and unknown risks, uncertainties, contingencies and other important factors, many of which are outside the control of the Group. Actual achievements, results,
performance or other future events or conditions may differ materially from those stated, implied and/or reflected in any forward-looking statements due to a variety of risks, uncertainties and other factors (including without limitation
those which are referable to general market or economic conditions, regulatory changes, geopolitical tensions such as the Russia-Ukraine war, the impact of the Covid-19 pandemic or as a result of data limitations and changes in
applicable methodologies in relation to ESG related matters). Any such forward-looking statements are based on the beliefs, expectations and opinions of the Group at the date the statements are made, and the Group does not assume,
and hereby disclaims, any obligation or duty to update, revise or supplement them if circumstances or management’s beliefs, expectations or opinions should change. For these reasons, recipients should not place reliance on, and are
cautioned about relying on, any forward-looking statements. No representations or warranties, expressed or implied, are given by or on behalf of the Group as to the achievement or reasonableness of any projections, estimates,
forecasts, targets, commitments, ambitions, prospects or returns contained herein.
Additional detailed information concerning important factors that could cause actual results to differ materially from this Presentation is available in our Annual Report and Accounts for the fiscal year ended 31 December 2021 filed with
the Securities and Exchange Commission (the “SEC”) on Form 20-F on 23 February 2022 (the “2021 Form 20-F”), our 1Q 2022 Earning Release furnished to the SEC on Form 6-K on 26 April 2022 (the “1Q 2022 Earnings Release”), our
Interim Financial Report for the six months ended 30 June 2022, furnished to the SEC on Form 6-K on 1 August 2022 (the “2022 Interim Report”) and our 3Q 2022 Earnings Release, which we expect to furnish to the SEC on Form 6-K
on 25 October 2022 (the “3Q 2022 Earnings Release”).
Alternative Performance Measures
This Presentation contains non-IFRS measures used by management internally that constitute alternative performance measures under European Securities and Markets Authority guidance and non-GAAP financial measures defined in
and presented in accordance with SEC rules and regulations (“Alternative Performance Measures”). The primary Alternative Performance Measures we use are presented on an “adjusted performance” basis which is computed by
adjusting reported results for the period-on-period effects of foreign currency translation differences and significant items which distort period-on-period comparisons. Significant items are those items which management and investors
would ordinarily identify and consider separately when assessing performance in order to better understand the underlying trends in the business.
Reconciliations between Alternative Performance Measures and the most directly comparable measures under IFRS are provided in our 2021 Form 20-F, our 1Q 2022 Earnings Release, our 2022 Interim Report and our 3Q 2022
Earnings Release, when filed, each of which are available at www.hsbc.com. Information in this Presentation was prepared as at 25 October 2022.

-- 32 of 33 --



-- 33 of 33 --